Medplus Health Services appointed Mr. Shrenik Soni as its Company Secretary and Compliance Officer (Key Managerial Personnel) effective July 21, 2026. The appointment was approved by the Board of Directors on the recommendation of the Nomination and Remuneration Committee. Mr. Soni is a Fellow Member of the Institute of Company Secretaries of India (ICSI) and holds an MBA in dual specialization from Osmania University.

Mr. Shrenik Soni brings over nine years of experience in corporate secretarial, legal, and compliance functions across sectors such as pharmaceuticals, manufacturing, and retail. His previous roles include handling board processes, fundraising, ESOPs, regulatory interfaces, and corporate restructuring. Before joining MedPlus, he was associated with HRV Pharma, SUVEN Life Sciences, and DUKES Group as Company Secretary.

The disclosure was made pursuant to Regulation 30 read with Schedule III of Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has enclosed the necessary details as per the SEBI Master Circular dated January 30, 2026. The appointment is effective immediately from the date of the board meeting.

Optival Health Solutions Private Limited, a subsidiary of medplus health services , has received suspension orders for drug licenses at three of its stores located in Karnataka. The orders were issued by the Assistant Director of the Drugs Control Administration in Bangalore Circle-3 and Belgaum Circle. The company disclosed that the suspensions were imposed due to violations under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The financial impact is estimated at a total potential revenue loss of ₹1.59 lakh.

The first order involves the suspension of the drug license for one day for a store situated at the Sarakki JP Nagar Metro Station. The second order also suspends the license for one day for a store located in Jaraganahalli. Both orders were received from the Bangalore Circle-3 authority. The third order, received from the Belgaum Circle authority, suspends the drug license for two days for a store situated at K C Road Chikkodi.

The following table details the specific actions taken and the estimated financial impact:

The disclosure was made in compliance with Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted by Gangadi Madhukar Reddy, Managing Director and Chief Executive Officer of Medplus Health Services Limited. The information is available on the company's website and the exchanges.